Federal award

KBR WYLE SERVICES, LLC

0038

Contract

Obligated and Ceiling

Obligated (net): $111,363,680.00
Ceiling (potential value, not spending): $105,171,314.28
Current value: $105,171,313.98
Gross positive obligations: $115,614,459.64

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient: KBR WYLE SERVICES, LLC · PMRAPK4NLQC1
Owner company: Wyle LaboratoriesBasis direct: the recipient is the company's own reviewed UEI.
Reported parent: KBR WYLE SERVICES, LLC · TGPKTMN8YL31
Awarding agency: Department of War · sub-agency 2100 · office W31P4Q
Funding agency: Department of War · sub-agency 2100
Product or service (PSC): R408 · SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT
Industry (NAICS): 541330 · ENGINEERING SERVICES
PIID: 0038
Parent vehicle (IDV PIID): W31P4Q05A0024
Award type code: C
Actions: 140 · Dec 9, 2010 to Mar 26, 2026
Why it is listed: gross positive obligations of $100k or more (contracts); reviewed company, $10k or more

Open this award on USAspending →

Action History140

Award actions
Date	FY	Mod	Action type	Obligation	Company in company totals
Mar 26, 2026	FY2026	BM	M	−$0.30	Wyle Laboratories
May 21, 2025	FY2025	BL	M	−$24,214.88	Wyle Laboratories
Apr 17, 2025	FY2025	BK	M	−$9,519.80	Wyle Laboratories
Feb 25, 2025	FY2025	BJ	M	−$19,160.40	Wyle Laboratories
Feb 25, 2025	FY2025	BJ	M	−$4,673.48	Wyle Laboratories
Mar 30, 2022	FY2022	BH	M	−$20,427.46	KBR Counted for KBR in company totals (reported by USAspending)
Mar 24, 2022	FY2022	BG	M	−$12,998.35	KBR Counted for KBR in company totals (reported by USAspending)
Nov 30, 2021	FY2022	BF	D	−$18,857.17	KBR Counted for KBR in company totals (reported by USAspending)
Nov 30, 2021	FY2022	BF	D	−$2,557.23	KBR Counted for KBR in company totals (reported by USAspending)
Sep 24, 2021	FY2021	BE	C	−$79,538.74	KBR Counted for KBR in company totals (reported by USAspending)
Sep 24, 2021	FY2021	BD	C	−$43.65	KBR Counted for KBR in company totals (reported by USAspending)
Aug 8, 2019	FY2019	BC	M	−$103.99	KBR Counted for KBR in company totals (reported by USAspending)
Aug 1, 2019	FY2019	BB	M	−$1,987.71	KBR Counted for KBR in company totals (reported by USAspending)
Jun 14, 2019	FY2019	BA	C	−$2,786.20	KBR Counted for KBR in company totals (reported by USAspending)
Apr 18, 2019	FY2019	B9	M	$0.00	KBR Counted for KBR in company totals (reported by USAspending)
Apr 11, 2019	FY2019	B8	M	$0.00	KBR Counted for KBR in company totals (reported by USAspending)
Mar 20, 2019	FY2019	B7	C	−$37,881.03	KBR Counted for KBR in company totals (reported by USAspending)
Aug 16, 2018	FY2018	1A	M	$0.00	KBR Counted for KBR in company totals (reported by USAspending)
Aug 16, 2018	FY2018	B6	C	−$797,028.67	KBR Counted for KBR in company totals (reported by USAspending)
Jun 26, 2018	FY2018	B5	C	−$37.67	KBR Counted for KBR in company totals (reported by USAspending)
Jun 16, 2017	FY2017	B3	D	−$267,784.67	KBR Counted for KBR in company totals (reported by USAspending)
Mar 28, 2017	FY2017	B2	D	$24,737.60	KBR Counted for KBR in company totals (reported by USAspending)
Mar 28, 2017	FY2017	B2	D	$2,000.00	KBR Counted for KBR in company totals (reported by USAspending)
Mar 14, 2017	FY2017	B1	G	$7,000.00	KBR Counted for KBR in company totals (reported by USAspending)
Dec 20, 2016	FY2017	99	M	$0.00	KBR Counted for KBR in company totals (reported by USAspending)
Nov 1, 2016	FY2017	98	B	$0.00	KBR Counted for KBR in company totals (reported by USAspending)
Oct 19, 2016	FY2017	97	G	$33,460.96	KBR Counted for KBR in company totals (reported by USAspending)
Oct 4, 2016	FY2017	96	B	$0.00	KBR Counted for KBR in company totals (reported by USAspending)
Sep 29, 2016	FY2016	95	B	$1,731,952.58	KBR Counted for KBR in company totals (reported by USAspending)
Sep 29, 2016	FY2016	95	B	$8,837,455.19	KBR Counted for KBR in company totals (reported by USAspending)
Sep 12, 2016	FY2016	94	B	−$154,180.24	KBR Counted for KBR in company totals (reported by USAspending)
Jul 28, 2016	FY2016	93	B	$105,098.24	KBR Counted for KBR in company totals (reported by USAspending)
Jul 28, 2016	FY2016	93	B	$146,693.04	KBR Counted for KBR in company totals (reported by USAspending)
Jul 12, 2016	FY2016	92	B	$16,346.88	Wyle Laboratories
Jun 14, 2016	FY2016	91	B	$54,274.88	Wyle Laboratories
Jun 1, 2016	FY2016	90	B	$82,093.34	Wyle Laboratories
Apr 13, 2016	FY2016	89	B	$3,975.40	Wyle Laboratories
Mar 31, 2016	FY2016	88	B	−$167,983.60	Wyle Laboratories
Mar 14, 2016	FY2016	87	B	$11,821,010.37	Wyle Laboratories
Feb 29, 2016	FY2016	86	B	$0.00	Wyle Laboratories
Feb 16, 2016	FY2016	85	M	$0.00	Wyle Laboratories
Feb 9, 2016	FY2016	84	B	$25,797.35	Wyle Laboratories
Feb 9, 2016	FY2016	84	B	$27,883.50	Wyle Laboratories
Jan 20, 2016	FY2016	83	B	$274,446.88	Wyle Laboratories
Jan 20, 2016	FY2016	83	B	$1,667,421.38	Wyle Laboratories
Dec 18, 2015	FY2016	82	B	$24,109.10	Wyle Laboratories
Dec 9, 2015	FY2016	81	M	$0.00	Wyle Laboratories
Dec 3, 2015	FY2016	80	G	$246,578.20	Wyle Laboratories
Nov 20, 2015	FY2016	79	B	$0.00	Wyle Laboratories
Nov 3, 2015	FY2016	78	B	$225,960.84	Wyle Laboratories
Oct 29, 2015	FY2016	77	B	$95,514.84	Wyle Laboratories
Oct 29, 2015	FY2016	77	B	$848,563.20	Wyle Laboratories
Oct 14, 2015	FY2016	76	M	$0.00	Wyle Laboratories
Sep 30, 2015	FY2015	75	B	−$0.02	Wyle Laboratories
Sep 14, 2015	FY2015	74	M	−$190.70	Wyle Laboratories
Aug 24, 2015	FY2015	73	B	$7,204,121.91	Wyle Laboratories
Aug 24, 2015	FY2015	73	B	$1,447,397.79	Wyle Laboratories
Jul 30, 2015	FY2015	72	B	$603,353.77	Wyle Laboratories
Jul 30, 2015	FY2015	72	B	$149,292.10	Wyle Laboratories
May 27, 2015	FY2015	71	B	$64,910.64	Wyle Laboratories
May 27, 2015	FY2015	71	B	$194,750.32	Wyle Laboratories
May 13, 2015	FY2015	70	B	−$0.08	Wyle Laboratories
May 1, 2015	FY2015	69	B	$15,922.05	Wyle Laboratories
Apr 22, 2015	FY2015	68	B	$0.00	Wyle Laboratories
Apr 14, 2015	FY2015	67	B	$0.00	Wyle Laboratories
Mar 11, 2015	FY2015	65	B	$7,696.40	Wyle Laboratories
Mar 11, 2015	FY2015	65	B	$37,408.83	Wyle Laboratories
Feb 10, 2015	FY2015	64	B	$84,086.21	Wyle Laboratories
Feb 10, 2015	FY2015	64	B	$117,824.04	Wyle Laboratories
Jan 30, 2015	FY2015	63	B	$1,018,477.10	Wyle Laboratories
Jan 30, 2015	FY2015	63	B	$4,578,971.61	Wyle Laboratories
Dec 17, 2014	FY2015	62	B	−$7.37	Wyle Laboratories
Dec 12, 2014	FY2015	61	B	$379,084.13	Wyle Laboratories
Dec 12, 2014	FY2015	61	B	$197,174.68	Wyle Laboratories
Nov 7, 2014	FY2015	60	G	$414,530.22	Wyle Laboratories
Sep 25, 2014	FY2014	59	G	$1,611,830.43	Wyle Laboratories
Sep 23, 2014	FY2014	58	M	−$303,360.94	Wyle Laboratories
Aug 8, 2014	FY2014	57	G	$153,501.86	Wyle Laboratories
Jun 27, 2014	FY2014	56	G	$813,836.01	Wyle Laboratories
Jun 27, 2014	FY2014	56	G	$6,898,129.40	Wyle Laboratories
May 15, 2014	FY2014	55	G	$44,850.10	Wyle Laboratories
May 15, 2014	FY2014	55	G	$19,253.30	Wyle Laboratories
Apr 24, 2014	FY2014	54	G	$589,790.40	Wyle Laboratories
Apr 24, 2014	FY2014	54	G	$15,447.00	Wyle Laboratories
Mar 28, 2014	FY2014	53	G	$44,456.92	Wyle Laboratories
Mar 28, 2014	FY2014	53	G	$57,836.26	Wyle Laboratories
Feb 19, 2014	FY2014	52	G	$1,822,629.52	Wyle Laboratories
Dec 26, 2013	FY2014	51	G	$5,803,870.76	Wyle Laboratories
Oct 30, 2013	FY2014	50	B	−$0.49	Wyle Laboratories
Sep 30, 2013	FY2013	49	M	−$64,803.49	Wyle Laboratories
Sep 20, 2013	FY2013	48	G	$74,394.79	Wyle Laboratories
Sep 16, 2013	FY2013	47	G	$926,639.73	Wyle Laboratories
Aug 26, 2013	FY2013	46	M	$0.00	Wyle Laboratories
Aug 15, 2013	FY2013	45	G	$38,070.63	Wyle Laboratories
Jul 2, 2013	FY2013	44	G	$620,590.56	Wyle Laboratories
Jun 13, 2013	FY2013	43	G	$86,499.88	Wyle Laboratories
Jun 7, 2013	FY2013	42	B	$0.00	Wyle Laboratories
May 10, 2013	FY2013	41	B	$420,117.36	Wyle Laboratories
Apr 26, 2013	FY2013	40	B	$0.00	Wyle Laboratories
Mar 15, 2013	FY2013	39	G	$565,456.10	Wyle Laboratories
Feb 14, 2013	FY2013	38	G	$305,148.26	Wyle Laboratories
Feb 7, 2013	FY2013	37	B	−$565,454.30	Wyle Laboratories
Jan 29, 2013	FY2013	36	G	$6,423,435.20	Wyle Laboratories
Dec 20, 2012	FY2013	35	B	−$8.24	Wyle Laboratories
Aug 29, 2012	FY2012	34	G	$2,508,926.87	Wyle Laboratories
Aug 26, 2012	FY2012	33	G	$222,805.84	Wyle Laboratories
Aug 14, 2012	FY2012	32	G	−$1,009,406.15	Wyle Laboratories
Aug 6, 2012	FY2012	31	B	−$275,454.79	Wyle Laboratories
Jul 27, 2012	FY2012	30	G	$3,510,334.65	Wyle Laboratories
Jun 22, 2012	FY2012	29	G	$966,206.20	Wyle Laboratories
Jun 13, 2012	FY2012	28	G	$0.00	Wyle Laboratories
Jun 11, 2012	FY2012	27	G	$626,456.32	Wyle Laboratories
May 21, 2012	FY2012	26	G	$313,209.04	Wyle Laboratories
May 3, 2012	FY2012	25	G	$199,992.78	Wyle Laboratories
Apr 12, 2012	FY2012	24	G	−$72,291.51	Wyle Laboratories
Mar 26, 2012	FY2012	23	G	$652,434.16	Wyle Laboratories
Mar 8, 2012	FY2012	22	G	$292,269.66	Wyle Laboratories
Feb 21, 2012	FY2012	21	G	$409,251.52	Wyle Laboratories
Jan 31, 2012	FY2012	20	G	$6,650,639.69	Wyle Laboratories
Dec 20, 2011	FY2012	19	G	$451,972.40	Wyle Laboratories
Nov 30, 2011	FY2012	18	G	$98,227.20	Wyle Laboratories
Nov 4, 2011	FY2012	17	G	$337,612.14	Wyle Laboratories
Sep 28, 2011	FY2011	16	C	$828,243.70	Wyle Laboratories
Sep 19, 2011	FY2011	15	C	$106,551.76	Wyle Laboratories
Aug 23, 2011	FY2011	14	C	−$338,036.32	Wyle Laboratories
Aug 4, 2011	FY2011	13	C	$49,300.00	Wyle Laboratories
Jul 19, 2011	FY2011	12	C	$737,523.98	Wyle Laboratories
Jul 7, 2011	FY2011	11	C	$418,911.00	Wyle Laboratories
Jun 30, 2011	FY2011	10	G	$498,828.99	Wyle Laboratories
May 26, 2011	FY2011	9	C	$259,309.32	Wyle Laboratories
May 11, 2011	FY2011	8	C	$2,301,720.36	Wyle Laboratories
Mar 30, 2011	FY2011	7	G	$8,994,770.33	Wyle Laboratories
Mar 22, 2011	FY2011	6	G	$2,933,503.16	Wyle Laboratories
Mar 17, 2011	FY2011	5	C	$0.00	Wyle Laboratories
Mar 4, 2011	FY2011	4	G	$467,748.90	Wyle Laboratories
Feb 24, 2011	FY2011	3	G	$1,183,527.63	Wyle Laboratories
Feb 2, 2011	FY2011	2	G	$4,310,195.95	Wyle Laboratories
Jan 20, 2011	FY2011	1	G	$708,875.08	Wyle Laboratories
Dec 9, 2010	FY2011	0	—	$4,421,950.97	Wyle Laboratories
Dec 9, 2010	FY2011	0	—	$0.00	Wyle Laboratories

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.